By analyzing E. coli protein levels, scientists found a surplus of membrane shuttle proteins that may play a role in ...

Three of these six pathogens are antibiotic-resistant Gram-negative bacteria. Recently, antibacterial drugs against ESBL-producing Gram-negative bacteria accounted for ∼15% (2 out of 13 ...

British physician and microbiologist Alexander Fleming, discoverer of penicillin nearly 100 years ago, was the first to warn ...

In fragile host, colonization and infection by MDROs pose a major clinical management challenge. Mainly carbapenem resistant Enterobacterales (CRE) and difficult to treat non fermentative ...

A study reveals alarming rates of antibiotic resistance in Gram-negative bacteria, highlighting the urgent need for ...

AbbVie has claimed FDA approval for Emblaveo, a new antibiotic product to treat complicated intra-abdominal infections (cIAI) ...

Infex Therapeutics, the Alderley Park-based anti-infectives specialist, has been awarded a £1m grant, alongside Germany’s ...

Cornell researchers have identified a key protein mechanism that helps bacteria expel antibiotics, making them more resistant ...

Antimicrobial resistance (AMR) is a major 21st century global health challenge. Multidrug-resistant Gram-negative bacteria (MDR-GNB) contribute a significant portion of the AMR threat, with an ...

A Cornell University-led collaboration has uncovered the equipment that enables bacteria to survive exposure to antibiotics: ...

AbbVie has announced that the US Food and Drug Administration (FDA) has approved its Pfizer-partnered Emblaveo ...